Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 883 results for "merck co"

SAP loan gets 100% hit rate, Meda expected to follow suit

The successful syndication, co-ordinated by Deutsche Bank, follows similar transactions for ZF Friedrichshafen and Merck KGaA, each of which had a 100% hit rate with banks. German automotive supplier ZF Friedrichshafen had to turn away dozens of ... GlobalCapital, 19 hours ago

17 images for merck co

Jutia Group, 3 days ago
Jutia Group, 1 week ago
Jutia Group, 3 weeks ago
North Penn Life, 1 week ago
Citybizlist, 1 week ago
Citybizlist, 1 week ago
Citybizlist, 1 week ago
Citybizlist, 1 week ago
SPi World News, 2 weeks ago
I Stock Analyst, 2 weeks ago

Potential Merck (MRK) Trade Targets 2.34% Return

Merck & Co Inc. ("MRK) was identified by MarketIntelligenceCenter.comaEUR(TM)s patented algorithms today after trading between $53.92 and $54.27 on Monday before closing at $54.05. A diagonal spread ...
 Individual.com2 days ago Merck (MRK) Trading Near $55.16 Resistance Level  Individual.com3 days ago Merck (MRK) Showing Resistance Near $54.94  Individual.com1 week ago Merck (MRK) Showing Support Near $53.38  Individual.com1 week ago
Jutia Group

Merck and Sanofi's BLA for paediatric hexavalent vaccine wins FDA acceptance

Merck & Co., Inc. and Sanofi Pasteur, the vaccines division of Sanofi, have received the FDA acceptance for review of biologics license application, or BLA, for the investigational pediatric hexavalent vaccine, DTaP5-IPV-Hib-HepB. If approved, it ...
 Individual.com3 days ago Investors Buy High Volume of Call Options on Merck & Co. (MRK)  American Banking News2 days ago Merck: FDA Accepts For Review BLA For Pediatric Hexavalent Vaccine  RTTNews.com4 days ago Market Update (NYSE:MRK): Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals  Minyanville3 days ago
Seeking Alpha

Gilead Sciences (GILD): Clear The Dockets And Settle With Merck Already

Summary The patent disputes of Gilead (GILD) with Merck (MRK) and AbbVie (ABBV) are not frivolous. Merck/Idenix have valid patents with claims on the structure of the Sovaldi active metabolite. AbbVie has 2 patents that claim Harvoni. The stakes ...
 Seeking Alpha3 days ago Gilead Sciences: Clear The Dockets And Settle With Merck Already  Seeking Alpha3 days ago

Merck Popular Amongst Latest 13F Filers

At Holdings Channel , we have reviewed the latest batch of the 20 most recent 13F filings for the 09/30/2014 reporting period, and noticed that Merck & Co., Inc ( NYSE: MRK ) was held by 13 of these funds. When hedge fund managers appear to be ...
 Forbes.com3 days ago

Merck unit to pay $31 million to settle fraud claims by U.S. states

(Reuters) - A subsidiary of Merck & Co has agreed to pay U.S. states $31 million to settle claims that it overcharged their Medicaid programs for an antidepressant it had sold at a discount to pharmacy companies, attorney generals from three states ...
 Reuters1 week ago Merck unit to pay $31 mln to settle fraud claims by U.S. states  Yahoo! Finance1 week ago State Highlights: Merck To Pay $31 Million To Settle States' Medicaid Fraud Claims  Kaiser Health News1 week ago

Merck executive touts principles and profits

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. Yet its unique ownership and organizational structure has been the driving force behind the company's long and stable growth, according to , chairman of the Board of ...
 Joins.com1 week ago Sun Pharma shares end nearly 2 pc up on Merck licensing pact  Business Standard1 month ago Sun Pharma shares gain nearly 3% on Merck licensing pact  Business Standard1 month ago Sun Pharma shares rally on licensing pact with Merck  Myiris1 month ago

UPDATE 1-Roche, Merck extend immunotherapy fight to breast cancer

(Adds Merck also presenting breast cancer data in December) LONDON Oct 17 (Reuters) - Swiss drugmaker Roche and U.S. group Merck & Co are to present data on their rival immunotherapy drugs in breast cancer in December, extending the novel ...
 Reuters UK1 week ago Roche, Merck & Co. Extend Immunotherapy Battle To Breast Cancer  BioSpace1 week ago Roche, Merck extend immunotherapy fight to breast cancer  Reuters1 week ago

Relative Strength Alert For Merck

The DividendRank formula at ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks ...
 Forbes.com1 week ago

Sun Pharma gains 2% on pact with Merck & Co for Tildrakizumab

Sun Pharma has entered into a licensing agreement with Merck & Co Inc for investigational therapeutic antibody candidate, Tildrakizumab. SI Reporter | Mumbai September 18, 2014 Last Updated at 09:56 IST On September 15, the state-owned construction firm ...
 Business Standard1 month ago Sun Pharma gains after inking pact with Merck  Business Standard1 month ago Sun Pharma in focus on inking pact with Merck  Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less